Symbols

Aardvark Therapeutics Soars 15% on Bank of America's Price Target Hike

Generated by AI AgentAinvest Movers Radar

Friday, Mar 28, 2025 5:34 am ET1min read

On March 28, 2025, Aardvark's stock price surged to $12.36 in pre-market trading, indicating a strong bullish sentiment among investors.

Bank of America has raised its price target for Aardvark TherapeuticsAARD-- from $22 to $26, maintaining a Buy rating. This move reflects the bank's confidence in the company's future performance and potential for growth.

This positive outlook from a major financial institution is likely to bolster investor confidence in AardvarkAARD-- Therapeutics, potentially driving further stock price appreciation.

Ainvest Movers Radar

Knowing stock market today at a glance

Latest Articles

Stay ahead of the market.

Get curated U.S. market news, insights and key dates delivered to your inbox.

Comments

﻿

Add a public comment...

No comments yet

AInvest
PRO

Editorial Disclosure & AI Transparency: Ainvest News utilizes advanced Large Language Model (LLM) technology to synthesize and analyze real-time market data. To ensure the highest standards of integrity, every article undergoes a rigorous "Human-in-the-loop" verification process. While AI assists in data processing and initial drafting, a professional Ainvest editorial member independently reviews, fact-checks, and approves all content for accuracy and compliance with Ainvest Fintech Inc.’s editorial standards. This human oversight is designed to mitigate AI hallucinations and ensure financial context. Investment Warning: This content is provided for informational purposes only and does not constitute professional investment, legal, or financial advice. Markets involve inherent risks. Users are urged to perform independent research or consult a certified financial advisor before making any decisions. Ainvest Fintech Inc. disclaims all liability for actions taken based on this information. Found an error?Report an Issue